 I. To determine the effect of the dose schedules of rhIL15 on the number and phenotype of peripheral blood mononuclear cells including: total white blood cell count; absolute lymphocyte count ALC; and total number of T cells and natural killer NK cells, as well as activated T cells, T cell subsets and NK cell subsets. 